Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IB Non-Small Cell Lung Cancer”

388 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 388 results

Early research (Phase 1)Ended earlyNCT04000529
What this trial is testing

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies

Who this might be right for
Non-small Cell Lung CarcinomaHead and Neck Squamous Cell CarcinomaEsophageal SCC+2 more
Novartis Pharmaceuticals 122
Not applicableStudy completedNCT01772225
What this trial is testing

NSCLC Burden of Illness Study

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 1
Large-scale testing (Phase 3)Active Not RecruitingNCT02511106
What this trial is testing

AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.

Who this might be right for
Stage IB-IIIA Non-small Cell Lung Carcinoma
AstraZeneca 682
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Testing effectiveness (Phase 2)Looking for participantsNCT06693336
What this trial is testing

An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)
ToLymph Inc. 42
Testing effectiveness (Phase 2)UnknownNCT05859373
What this trial is testing

To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer.

Who this might be right for
Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 78
Testing effectiveness (Phase 2)Looking for participantsNCT06528847
What this trial is testing

Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma

Who this might be right for
Non-Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 62
Early research (Phase 1)Active Not RecruitingNCT05704634
What this trial is testing

A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combination With antiPD1 Antibody Cemiplimab for Patients With Non-small Cell Lung Cancer.

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 56
Early research (Phase 1)Study completedNCT02575404
What this trial is testing

GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients

Who this might be right for
MelanomaNon-Small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck
Providence Health & Services 36
Not applicableStudy completedNCT00450281
What this trial is testing

S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 981
Early research (Phase 1)Study completedNCT04895579
What this trial is testing

Lung Cancer With Copanlisib and Durvalumab

Who this might be right for
Non Small Cell Lung Cancer
Zhonglin Hao 11
Testing effectiveness (Phase 2)Looking for participantsNCT06996782
What this trial is testing

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Advanced or Metastatic Non-small Cell Lung Cancer
AstraZeneca 152
Large-scale testing (Phase 3)Study completedNCT03735121
What this trial is testing

Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 438
Testing effectiveness (Phase 2)UnknownNCT00398385
What this trial is testing

Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Center, Korea 170
Early research (Phase 1)Study completedNCT00254384
What this trial is testing

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IA Lung Non-Small Cell Carcinoma AJCC v7Stage IB Lung Non-Small Cell Carcinoma AJCC v7+4 more
M.D. Anderson Cancer Center 50
Early research (Phase 1)Active Not RecruitingNCT04505267
What this trial is testing

NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+11 more
M.D. Anderson Cancer Center 34
Large-scale testing (Phase 3)Active Not RecruitingNCT02595944
What this trial is testing

Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)

Who this might be right for
Stage IB Lung Non-Small Cell Carcinoma AJCC v7Stage II Lung Non-Small Cell Cancer AJCC v7Stage IIIA Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 903
Early research (Phase 1)Ended earlyNCT04916236
What this trial is testing

Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers

Who this might be right for
Pancreatic CancerColorectal CancerNon-small Cell Lung Cancer+1 more
The Netherlands Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT02581787
What this trial is testing

SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung Carcinoma
Maximilian Diehn 28
Not applicableUnknownNCT03838588
What this trial is testing

The Tracking Molecular Evolution for NSCLC (T-MENC) Study

Who this might be right for
Lung NeoplasmsLung CancerNonsmall Cell Lung Cancer+1 more
Geneplus-Beijing Co. Ltd. 200
Load More Results